Press Release · Press Releases
GIL INVESTOR NOTICE: Gildan Activewear Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 14, 2026 Deadline
SAN DIEGO, Nov. 8, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Gildan Activewear Inc. (NYSE: GIL) publicly traded securities between February 19, 2025 and June 15, 2026, both dates inclusive (the "Class Period"), have...
This press release summary is reproduced from the issuer's public feed.
Read the full release at PR NewswireOriginal publisher: PR Newswire
Spotted an error? Request a correction · Corrections Policy
Related stories
Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications
– HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase 4 cohort, participants reported statistically significant improvements in satisfaction with facial appearance and skin quality...
PR Newswire ·
Cleaner Bedroom Air May Help Manage Blood Sugar in Prediabetes
NEW YORK, Nov. 8, 2026 /PRNewswire/ -- Using portable filters to reduce exposure to air pollution during sleep may stabilize the large spikes in blood sugar experienced by people with prediabetes, a condition in which sugar (glucose) levels are higher than normal, a new study shows....
PR Newswire ·
Amplifon Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Social Security Numbers and Health Records Are Exposed
National class action law firm offers free, confidential case evaluations to Amplifon hearing-care members, patients, and others whose information may have been exposed. NEWTOWN, Pa., Nov. 8, 2026 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating...
PR Newswire ·
Johnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer
First-of-its-kind dual-antigen-targeted bispecific regimen of pasritamig and JNJ-9401 directed at two prostate cancer proteins, KLK2 and PSMA, using complementary signals to activate T cells against cancer Deep and sustained PSA responses observed with every-six-week dosing, with 73% (11...
PR Newswire ·
Le GSMA MWC26 Doha ouvre ses portes avec un appel à l'harmonisation des normes industrielles mondiales et à la réduction de la fracture numérique au Moyen-Orient et en Afrique du Nord
Des opérateurs, des leaders technologiques, des décideurs politiques et des innovateurs se réunissent aujourd'hui à Doha pour trois jours d'exposition, de collaboration et de débats sur l'avenir de la connectivité au Moyen-Orient et en Afrique du Nord DOHA, Qatar, 8 novembre 2026...
PR Newswire ·
essential COSTA RICA nommée Marque territoriale de l'année aux City Nation Place Awards à Londres
Le Costa Rica a reçu trois distinctions : Marque territoriale de l'année, Meilleure mobilisation citoyenne et une mention spéciale dans la catégorie Meilleure stratégie de communication. essential COSTA RICA est la première marque nationale à recevoir deux fois le prix de la Marque...
PR Newswire ·